CCT5 expression exhibited a significant positive correlation with TMB in patients with GBM, KICH, KIRC, LGG, LUAD, SKCM, STAD, and UCEC, and a significant negative correlation with THCA (*p < 0.05, **p < 0.01). Here, CCT5 is linked to glioblastoma.